Treatment outcomes of mucosal melanoma of head and neck: Efficacy of immune checkpoint inhibitors for advanced disease

Treatment outcomes of mucosal melanoma of head and neck: Efficacy of immune checkpoint inhibitors for advanced disease

BackgroundHead and neck mucosal melanoma (HNMM) is a rare and aggressive subtype of melanoma. HNMM often develops as a recurrent or metastatic disease, and its prognosis is worse than that of cutaneous melanoma. Recent large-scale clinical studies have reported favorable outcomes with immune checkpo...

Full description

Bibliographic Details
Main Authors: Shusuke Ohshima, Yushi Ueki, Yusuke Yokoyama, Takeshi Takahashi, Ryusuke Shodo, Keisuke Yamazaki, Ryuichi Okabe, Hiroshi Matsuyama, Takafumi Togashi, Sumiko Takatsuka, Tatsuya Takenouchi, Arata Horii
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Surgery
Subjects:
Head and neck mucosal melanoma
Advanced disease
Immune checkpoint inhibitor
Immune-related adverse events
Overall Response Rate (ORR)
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2022.1032626/full

Internet

https://www.frontiersin.org/articles/10.3389/fsurg.2022.1032626/full

Similar Items